From the carrier of active substance to drug delivery systems

Barbara Jadach

Abstract


Development and innovation all the time are in interests of pharmaceutical science and evaluation of different dosage forms. They are concerned with the aim of compliance of patients. All the time different research groups try to develop and improve form of drugs to receive better bioavailability or strict control of dose, place and time of action of active substances. This is possible by using different excipients; biodegradable, biocompatible polymers that work like a carriers; developing simple drug delivery systems, which in time became more and more complicated; nanotechnology that control size, shape and multi-functionality of particulate drug delivery systems. This review shows the main points in the evaluation of pharmaceutical researches from simple carriers of active substances to drug delivery systems.


Keywords


carrier; drug delivery system; sustained release; zero-order kinetic; nanoparticle

References


Hoffman AS. The origins and evolution of “controlled” drug delivery systems. J Contr Rel. 2008; 132: 153–163

Lee BK, Yun YH, Park K. Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. Chem Eng Sci. 2015; 24 (125): 158–164

Anselmo AC, Mitragotri S. An Overview of Clinical and Commercial Impact of Drug Delivery Systems. J Control Rel. 2014; 28 (190): 15–28

Krówczyński L. Postacie leku o przedłużonym działaniu. Warszawa PZWL 1980 p. 64-114

Romansky MJ, Rittman GE. Method of Prolonging Action of Penicillin. Science 1944; 100: 196-198

Romansky MJ, Rittman GE. Penicylin blood levels for 24 hours following the single intramuscular injection of Calcium Penicyline in Beeswax and Peanut Oil. New England J M. 1945; 233: 577-582

Choay A, Choay H. Prolingation des effets de l’insuline par association á la polyvinylpyrrolidone. Ann phsarm franc. 1947; 5: 420-429

Chaudhary NC and Saunders L. Sustained release of drugs from ion-exchange resins. J Pharm Pharmacol. 1956; 8: 975–986

Robinson MJ, Swintosky JV. Sulfaethylthiadiazole V. Design and study of an oral sustained release dosage form. J Pharm Sci. 1959; 48(8): 473–478

Keating JW. Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment there with. 1961. US Patent 2,990,332

Hays EE. Pharmaceutical compositions containing a resin narcotic compound. 1961. US Patent 3,035,979

Keating JW. Pharmaceutical preparations comprising phosphorous containing cation-exchange resins having a basic drug adsorbed thereon; and treatment tere with. 1964. US Patent 3,143,465

Folkman J, Long DM. The use of silicone rubber as a carrier for prolonged drug therapy. Surg Res. 1964; 4: 139–142

Bangham AD, Horne RH. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol. 1964; 8(5): 660-668

Folkman J, Long DM, Rosenbau R. Silicone rubber - a new diffusion property useful for general anesthesia. Science. 1966; 154: 148–149

Schmitt E, Polistina R. Surgical sutures. 1967. US Patent 3,297,033

Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature. 1976; 263: 797–800

Zaffaroni A. Bandage for administering drugs. 1971. US Patent 3,598,122

Boswell G, Scribner R. Polylactide-drug mixtures. 1973. US Patent 3,773,919

Gregoriadis G, Swain CP, Wills EJ, Tavill AS. Drug carrier potential of liposomes in cancer chemotherapy. Lancet. 1974; 1: 1313–1316

Gregoriadis G. The carrier potential of liposomes in biology and medicine. N Eng J Med. 1976; 295: 704–710

Kreuter J, Speiser P. In vitro studies of poly(methylmethacrylate) adjuvants. J Pharm Sci. 1976; 65: 1624–1627, [PubMed: 993993]

Buhleier E, Wehner W, Vogtle F. Cascade- and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis. 1978; 2: 155–8

Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst dendritic macromolecules. Polymer J. 1985; 17: 117–32

Duncan R, Kopecek J. Soluble synthetic-polymers as potential-drug carriers. Adv Polymer Sci. 1984; 57: 51–101

Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res. 1984; 44(5): 2115–2121

Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, et al. Polymer micelles as novel drug carrier - adriamycin-conjugated poly(ethylene glycol) poly(aspartic acid) block copolymer. J Control Rel. 1990; 11: 269–278

Schwarz C, Mehnert W, Lucks JS, Müller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Rel. 1994; 30(1): 83-96

Sriwongjanya M, Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm. 1998; 46: 321-327

Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000; 50(1): 27–46

Cheng Y, Xu Z, Ma M, Xu T. Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration. J Pharm Sci. 2008; 97(1): 123-143

Grill AE, Johnston NW, Sadhukha T, Panyam J. A review of select recent patents on novel nanocarriers. Recent Patents on Drug Delivery and Formulation. 2009; 3(2): 137–142

Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003; 2: 347–360

Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014; 13(11): 813–827

Kowalczuk A, Trzcinska R, Trzebicka B, Müller AHE, Dworak A, Tsvetanov CB. Loading of polymer nanocarriers: Factors, mechanisms and applications. Prog Poly Sci. 2014; 39: 43–86

Čerpnjak K, Zvonar A, Gašperlin M,Vrečer F, Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs, Acta Pharm 63 (2013) 427-445

Dening TJ, Rao S, Thomas N, Prestidge CA. Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems. The AAPS Journal. 2016; 18(1) doi: 10.1208/s12248-015-9824-7

Rigon RB, Oyafuso MH, Fujimura AT, Gonçalez AL, do Prado AH, Gremião APD, et al. Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review. BioMed Research Inter. 2015 Article ID 841817, 22 pages; http://dx.doi.org/10.1155/2015/841817

Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature Rev Drug Discov. 2005; 4(2): 145–160

Mahore JG, Wadher KJ, Umekar MJ, Bhoyar PK. Ion exchange resins: pharmaceutical applications and recent advancement. Int J Pharm Sci Rev Res. 2010; 1(2): 8-13

Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013; 65: 36–48

Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Poly Sci. 2014; 39: 268–307

Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005; 295: 221–33

Villiers A. Sur la fermentation de la fécule par l’action du ferment butyrique. C R Acad Sci. 1891; 112: 536–538

Kurkov SV, Loftsson T. Cyclodextrins. Inter J Pharm. 2013; 453: 167–180

Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov. 2004; 3: 1023-1035

Vallet-Regí M, Balas F, Arcos D. Mesoporous Materials for drug delivery. Angew Chem Int. 2007; 46: 7548-7558


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Medical Science

Copyright 2016 by Journal of Medical Sciences